The number of people diagnosed with transthyretin amyloidosis (ATTR) in the U.S. is climbing, a surge researchers attribute to better medical awareness and more advanced diagnostic tools. This increase spans both new diagnoses and the total number of people living with the condition, which includes hereditary ATTR with…